How to make me like your paper (part 2) Source: ERS Lung Science Conference 2021 Year: 2021
Rescue2-Monitor (R2M) study: an overview of screened patients. Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021
Expression of claudins 1, 2, 3, 4, 5 and 7 in lung cancer Source: Annual Congress 2009 - Lung cancer biology Year: 2009
Are we missing asthma COPD overlap (ACO) diagnosis among patient with COPD?Alameeri Amel(1), Dudina Alexandra(1) , Stephen Lane(1), Kennedy Merian(2) Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019
How to assess central aspects of a scientific paper (ethics, originality, structure) Source: International Congress 2015 – Review articles and abstracts Year: 2015
Expression of claudins 1, 2, 3, 4, 5 and 7 in usual interstitial pneumonia and sarcoidosis Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease Year: 2007
Increasing smoking cessation (SC) rates through Facebook (FB). ("ToKANA") Source: International Congress 2019 – Challenges in tobacco control and cessation Year: 2019
Thymolipoma (case report) Source: Eur Respir J 2005; 26: Suppl. 49, 307s Year: 2005
Chronic alcoholics[scquote] (CA) knowledge (KN) and social stigmatisation (ST) regarding tuberculosis (TB) Source: Eur Respir J 2001; 18: Suppl. 33, 322s Year: 2001
Pooled analyses of five phase 2b studies support dose selection of glycopyrrolate-formoterol (GFF) MDI (PT003) 18/9.6 μg for phase III development Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013
Patients‘ and family members‘ worries and concerns regarding ‘swine flu‘: A mixed methods study Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease Year: 2010
Effectiveness of N-acetyl cyctein (NAC) to reduce cough when used together with other over-the-counter (OTC) in common cold (a preliminary study) Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases Year: 2008
Asthma control (AC) 1 year after pulmonary rehabilitation (PR) Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions? Year: 2011
The effect of reverse causation (RC) and confounding-by-indication (CbI) on the association between infant antibiotic use and asthma risk – A systematic review and meta-analysis Source: Annual Congress 2010 - Paediatric respiratory epidemiology: early origins of childhood asthma Year: 2010
Dyspnoea and its measurement (CME article) Source: ISSN=ISSN 1810-6838, ISBN=, page=100 Year: 2004
COPD assessment: I, II, III, IV and/or A, B, C, D Source: Eur Respir J 2014; 43: 949-950 Year: 2014
Hypoplasia of lung (frequency, particular features of course, clinic, diagnosis, results of treatment) Source: Eur Respir J 2007; 30: Suppl. 51, 650s Year: 2007
Safety, pharmacodynamics (PD) and pharmacokinetics (PK) of darotropium (DARO) and vilanterol (VI) in healthy subjects: Two phase 1 studies Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013